POLMARACE-2 CAPSULE
MRP: 1,750
Packaging: 10 X 10
Pack Type: tablet
Composition:
Polmacoxib Capsules 2 mg
Indication:
used in the treatment of osteoarthritis of knee and hip joints.
Description:
Polmacoxib is a dual-action anti-inflammatory drug combining selective COX-2 inhibition with carbonic anhydrase inhibition, designed to reduce inflammation and pain with minimal gastrointestinal and cardiovascular risk compared to traditional NSAIDs.
It is indicated primarily for osteoarthritis and rheumatoid arthritis, offering effective symptom relief with a low dose (2 mg) and improved gastrointestinal tolerability. Polmacoxib represents the next-generation NSAID option for long-term management of joint diseases.
Tags:
- Dual action: COX-2 and carbonic anhydrase inhibition
- Lower gastrointestinal and cardiovascular risk than many NSAIDs
- Effective in reducing joint pain, swelling, and stiffness
- Once-daily dose with high tolerability
- Suitable for long-term use in chronic arthritis
Usage Information
Dosage
Usual adult dose: One capsule (2 mg) once daily, with or without food Duration depends on clinical condition and response Use under medical supervision, especially in chronic therapy
Side Effects
Mild nausea or dizziness Headache Flatulence or stomach discomfort (rare) Rarely: Skin rash or fluid retention Lower incidence of gastric ulceration compared to non-selective NSAIDs
Contraindications
Hypersensitivity to Polmacoxib or sulfonamides Severe hepatic or renal impairment Active peptic ulcer or GI bleeding History of ischemic heart disease or stroke (use with caution) Pregnancy and lactation (not recommended unless prescribed)